Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil as Adjunctive Therapy in Drug-Resistant Focal-Onset Seizures
CTR20191693Phase 3Suspended
- Sponsor
- UCB
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of padsevonil in refractory focal epilepsy, sponsored by UCB. Started Oct 2019; status: suspended.
02
Drugs
padsevonil
03
Conditions
refractory focal epilepsy
Beyond the preview
Go deeper on CTR20191693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191693.